Vitamin E for hot flashes after breast cancer

Evidence label: Minimal benefit / unlikely clinically meaningful · Clinical goal: reduce hot-flash frequency and burden in breast-cancer survivors

Evidence at a glance

Population: 120 breast-cancer survivors evaluated for toxicity; 105 completed the first treatment period.
Intervention: vitamin E 800 IU daily for four weeks and matching placebo for four weeks in crossover order.
Result: both periods improved similarly; crossover analysis suggested about one fewer hot flash per day with vitamin E.

What was studied

After a one-week baseline, participants received four weeks of vitamin E and four weeks of placebo in randomized crossover order. Diaries tracked frequency, severity and toxicity.

The first-period comparison found hot-flash frequency reductions of 25% with vitamin E and 22% with placebo (P=.90).

What the evidence shows

A crossover analysis found a statistically detectable but small difference—approximately one fewer hot flash per day than placebo. The investigators described the clinical effect as minimal.

Vitamin E does not treat breast cancer or change recurrence risk. A symptom-scale difference should not be interpreted as anticancer activity.

Limits and uncertainty

The trial was short, and crossover analyses can be affected by period and carryover effects. The small difference may not meet an individual patient’s threshold for worthwhile benefit.

The studied 800-IU dose is far above ordinary dietary intake; this record does not generalize to vitamin-E-rich foods.

Safety and practical context

High-dose vitamin E supplements can increase bleeding risk, especially with anticoagulants, antiplatelet drugs or around surgery. NIH ODS also notes concern about hemorrhagic stroke at high supplemental intakes.

Review total dose, formulation and medicines before use. A supplement is not automatically safer because it is a vitamin.

Questions for the care team

Would one fewer hot flash per day be meaningful enough to justify a high-dose supplement?
Do anticoagulants, antiplatelet medicines or upcoming procedures increase bleeding risk?
What nonhormonal options have stronger evidence for my situation?

Sources

Literature searched: October 15, 2026 · Record appraised: October 15, 2026

Educational evidence summary, not personal medical advice. Research regimens describe what was studied; they are not personal prescribing instructions and should not replace cancer treatment or individualized supportive care.